SEARCH

SEARCH BY CITATION

References

  • 1
    CDC. Centers for Disease Control and Prevention: National Health Interview Survey Data [Internet]. Centers for Disease Control and Prevention, Atlanta, GA, 2006. [updated 27 Apr 2009; accessed 16 Jan 2013.] Available from URL: http://www.cdc.gov/asthma/nhis/06/table4-1.htm
  • 2
    Krishnan V, Diette GB, Rand CS et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am. J. Respir. Crit. Care Med. 2006; 174: 633638.
  • 3
    CDC. Centers for Disease Control and Prevention: National Health Interview Survey Data [Internet]. Centers for Disease Control and Prevention, Atlanta, GA, 2010. [updated 10 Jan 2010; accessed 16 Jan 2013.] Available from URL: http://www.cdc.gov/asthma/nhis/2010/data.htm
  • 4
    Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J. Allergy Clin. Immunol. 2011; 127: 145152.
  • 5
    HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) [Internet]. Agency for Healthcare Research and Quality, Rockville, MD, 1998–2010. [updated 10 Sep 2012; accessed 14 Jan 2013.] Available from URL: http://www.hcup-us.ahrq.gov/nisoverview.jsp
  • 6
    Papadopoulos NG, Christodoulou I, Rohde G et al. Viruses and bacteria in acute asthma exacerbations – a GA(2) LEN-DARE systematic review. Allergy 2011; 66: 458468.
  • 7
    Pelaia G, Vatrella A, Gallelli L et al. Respiratory infections and asthma. Respir. Med. 2006; 100: 775784.
  • 8
    Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest 2006; 130: 12031210.
  • 9
    Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 2011; 12: 631638.
  • 10
    Dahl ME, Dabbagh K, Liggitt D et al. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat. Immunol. 2004; 5: 337343.
  • 11
    Griffin MR, Coffey CS, Neuzil KM et al. Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch. Intern. Med. 2002; 162: 12291236.
  • 12
    Kloepfer KM, Olenec JP, Lee WM et al. Increased H1N1 infection rate in children with asthma. Am. J. Respir. Crit. Care Med. 2012; 185: 12751279.
  • 13
    Miller EK, Griffin MR, Edwards KM et al. Influenza burden for children with asthma. Pediatrics 2008; 121: 18.
  • 14
    Agency for Healthcare Research and Quality. Nationwide Inpatient Sample Trends Supplemental (NIS-Trends) Files [Internet]. Agency for Healthcare Research and Quality, Rockville, MD, 1998–2005. [updated 15 May 2008; accessed 14 Jan 2013.] Available from URL: http://www.hcup-us.ahrq.gov/db/nation/nis/nistrends.jsp
  • 15
    Cryer JSCK. Time Series Analysis with Applications in R, 2nd edn. Springer, New York, 2008.
  • 16
    Mandelcwajg A, Moulin F, Menager C et al. Underestimation of influenza viral infection in childhood asthma exacerbations. J. Pediatr. 2010; 157: 505506.
  • 17
    Dulek DE, Peebles RS, Jr. Viruses and asthma. Biochim. Biophys. Acta 2011; 1810: 10801090.
  • 18
    Papadopoulos NG, Xepapadaki P, Mallia P et al. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy 2007; 62: 457470.
  • 19
    Polgreen PM, Chen Y, Pennock DM et al. Using internet searches for influenza surveillance. Clin. Infect. Dis. 2008; 47: 14431448.
  • 20
    Signorini A, Segre AM, Polgreen PM. The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic. PLoS ONE 2011; 6: e19467.
  • 21
    Ginsberg J, Mohebbi MH, Patel RS et al. Detecting influenza epidemics using search engine query data. Nature 2009; 457: 10121014.
  • 22
    Corley CD, Cook DJ, Mikler AR et al. Using Web and social media for influenza surveillance. Adv. Exp. Med. Biol. 2010; 680: 559564.
  • 23
    Rowe BH, Spooner CH, Ducharme FM et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst. Rev. 2007; (1): CD000195.
  • 24
    Rowe BH, Wong E, Blitz S et al. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Acad. Emerg. Med. 2007; 14: 833840.
  • 25
    Gielen V, Johnston SL, Edwards MR. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur. Respir. J. 2010; 36: 646654.
  • 26
    Rowe BH, Vethanayagam D. The role of inhaled corticosteroids in the management of acute asthma. Eur. Respir. J. 2007; 30: 10351037.
  • 27
    Busse WW, Morgan WJ, Gergen PJ et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl. J. Med. 2011; 364: 10051015.
  • 28
    Lalezari J, Campion K, Keene O et al. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch. Intern. Med. 2001; 161: 212217.
  • 29
    Hanania NA, Sockrider M, Castro M et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J. Allergy Clin. Immunol. 2004; 113: 717724.
  • 30
    Sambhara S, McElhaney JE. Immunosenescence and influenza vaccine efficacy. Curr. Top. Microbiol. Immunol. 2009; 333: 413429.
  • 31
    Osterholm MT, Kelley NS, Sommer A et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 2012; 12: 3644.
  • 32
    Ginde AA, Tsai CL, Blanc PG et al. Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department. Jt Comm. J. Qual. Patient Saf. 2008; 34: 678680.
  • 33
    Marsden-Haug N, Foster VB, Gould PL et al. Code-based syndromic surveillance for influenzalike illness by International Classification of Diseases, Ninth Revision. Emerg. Infect. Dis. 2007; 13: 207216.